Health
Moderna’s Experimental mRNA HIV Vaccine Human Trail Starts This Week – IFLScience
Pharmaceutical company Moderna, maker of one of the COVID-19 vaccines, is set to begin a Phase I clinical trial on a different…
Pharmaceutical company Moderna, maker of one of the COVID-19 vaccines, is set to begin a Phase I clinical trial on a different mRNA vaccine this week, this time tackling HIV. The HIV, or human immunodeficiency virus, is responsible for the deadliest pandemic…
Continue Reading